UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma

Annals of nuclear medicine, 2023-02, Vol.37 (2), p.139-150

2023

Link zum Volltext

Verfügbarkeit prüfen

Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma

Annals of nuclear medicine, 2022-03, Vol.36 (3), p.256-266

2022

Link zum Volltext

Verfügbarkeit prüfen

Genomic and Glycolytic Entropy Are Reliable Radiogenomic Heterogeneity Biomarkers for Non-Small Cell Lung Cancer

International journal of molecular sciences, 2023-02, Vol.24 (4), p.3988

2023

Link zum Volltext

Verfügbarkeit prüfen

Incremental yield of serial sputum examinations in the diagnosis of pulmonary tuberculosis in Taiwan: Findings of a pragmatic trial

Journal of microbiology, immunology and infection, 2023-12, Vol.56 (6), p.1245-1252

2023

Link zum Volltext

Verfügbarkeit prüfen

Glycemic control and radiographic manifestations of tuberculosis in diabetic patients

PloS one, 2014-04, Vol.9 (4), p.e93397-e93397

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety and treatment completion of latent tuberculosis infection treatment in the elderly population—A prospective observational study in Taiwan

International journal of infectious diseases, 2020-07, Vol.96, p.550-557

2020

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations

Journal of thoracic oncology, 2015-05, Vol.10 (5), p.793-799

2015

Link zum Volltext

Verfügbarkeit prüfen

Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing

European journal of cancer (1990), 2021-10, Vol.156, p.1-11

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment outcomes for multidrug-resistant tuberculosis in Eastern Taiwan

Ci ji yi xue za zhi, 2019-01, Vol.31 (1), p.35-39

2019

Link zum Volltext

Verfügbarkeit prüfen

Presence of pleural effusion is associated with a poor prognosis in patients with epidermal growth factor receptor–mutated lung cancer receiving tyrosine kinase inhibitors as first‐line treatment

Asia-Pacific journal of clinical oncology, 2017-08, Vol.13 (4), p.304-313

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study

Annals of nuclear medicine, 2024-08, Vol.38 (8), p.647-658

2024

Link zum Volltext

Verfügbarkeit prüfen

Pleural Empyema Secondary to Rupture of Amoebic Liver Abscess

Internal Medicine, 2012, Vol.51(5), pp.471-474

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Motesanib (AMG-706) in Combination With Paclitaxel and Carboplatin in East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2017-11, Vol.35 (32), p.3662-3670

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment Outcomes of Multidrug-Resistant Tuberculosis in Taiwan: Tackling Loss to Follow-up

Clinical infectious diseases, 2018-07, Vol.67 (2), p.202-210

2018

Link zum Volltext

Verfügbarkeit prüfen

Mitigating treatment failure of pulmonary pre-extensively drug-resistant tuberculosis: The role of new and repurposed drugs

Journal of microbiology, immunology and infection, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study

The lancet respiratory medicine, 2024-02, Vol.12 (2), p.141-152

2024

Link zum Volltext

Verfügbarkeit prüfen

Effective Interventions and Decline of Antituberculosis Drug Resistance in Eastern Taiwan, 2004–2008

PloS one, 2012-02, Vol.7 (2), p.e31531-e31531, Article e31531

2012

Link zum Volltext

Verfügbarkeit prüfen

Plasma Concentrations of sTREM-1 as Markers for Systemic Adverse Reactions in Subjects Treated With Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection

Frontiers in microbiology, 2022-03, Vol.13, p.821066-821066

2022

Link zum Volltext

Verfügbarkeit prüfen

Enhancing the sequence coverage of nanodiamond-extracted early secretory proteins from the Mycobacterium tuberculosis complex

Analytical methods, 2024-06, Vol.16 (22), p.3464-3474

2024

Link zum Volltext

Verfügbarkeit prüfen

Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor-mutated lung adenocarcinoma

Medicine (Baltimore), 2020-07, Vol.99 (29), p.e21275-e21275

2020

Link zum Volltext

Verfügbarkeit prüfen

Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma

PloS one, 2020, Vol.15 (12), p.e0244502

2020

Link zum Volltext

Verfügbarkeit prüfen

Correlating Reiff scores with clinical, functional, and prognostic factors: characterizing noncystic fibrosis bronchiectasis severity: validation from a nationwide multicenter study in Taiwan

European journal of medical research, 2024-05, Vol.29 (1), p.286-286, Article 286

2024

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan

International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.2869-2881

2021

Link zum Volltext

Verfügbarkeit prüfen

Performance of Nucleic Acid Amplification Tests in Patients with Presumptive Pulmonary Tuberculosis in Taiwan

Infectious diseases and therapy, 2022-04, Vol.11 (2), p.871-885

2022

Link zum Volltext

Verfügbarkeit prüfen

Is it appropriate to routinely use a nucleic acid amplification test for the diagnosis of tuberculosis?

The Kaohsiung journal of medical sciences, 2011-04, Vol.27 (4), p.138-143

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(50)
Tagungsberichte
(2)

Sprache

Englisch
(51)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma

Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma

Genomic and Glycolytic Entropy Are Reliable Radiogenomic Heterogeneity Biomarkers for Non-Small Cell Lung Cancer

Incremental yield of serial sputum examinations in the diagnosis of pulmonary tuberculosis in Taiwan: Findings of a pragmatic trial

Glycemic control and radiographic manifestations of tuberculosis in diabetic patients

Safety and treatment completion of latent tuberculosis infection treatment in the elderly population—A prospective observational study in Taiwan

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations

Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing

Treatment outcomes for multidrug-resistant tuberculosis in Eastern Taiwan

Presence of pleural effusion is associated with a poor prognosis in patients with epidermal growth factor receptor–mutated lung cancer receiving tyrosine kinase inhibitors as first‐line treatment

Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study

Pleural Empyema Secondary to Rupture of Amoebic Liver Abscess

Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Motesanib (AMG-706) in Combination With Paclitaxel and Carboplatin in East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer

Treatment Outcomes of Multidrug-Resistant Tuberculosis in Taiwan: Tackling Loss to Follow-up

Mitigating treatment failure of pulmonary pre-extensively drug-resistant tuberculosis: The role of new and repurposed drugs

Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study

Effective Interventions and Decline of Antituberculosis Drug Resistance in Eastern Taiwan, 2004–2008

Plasma Concentrations of sTREM-1 as Markers for Systemic Adverse Reactions in Subjects Treated With Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection

Enhancing the sequence coverage of nanodiamond-extracted early secretory proteins from the Mycobacterium tuberculosis complex

Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor-mutated lung adenocarcinoma

Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma

Correlating Reiff scores with clinical, functional, and prognostic factors: characterizing noncystic fibrosis bronchiectasis severity: validation from a nationwide multicenter study in Taiwan

Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan

Performance of Nucleic Acid Amplification Tests in Patients with Presumptive Pulmonary Tuberculosis in Taiwan

Is it appropriate to routinely use a nucleic acid amplification test for the diagnosis of tuberculosis?

Suchergebnisse filtern